Pituitary Adenylate Cyclase Activating Peptide Deficient Mice Exhibit Impaired Thymic and Extrathymic Regulatory T Cell Proliferation during EAE

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Tan, Yossan Var ^a   Abad, Catalina ^a   Wang, Yuqi ^a   Lopez, Robert ^a   Waschek, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN 7; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; FLOW CYTOMETRY; IMMUNOMODULATION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; THYMUS; WILD TYPE;

ANIMALS; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MICE; MICE, KNOCKOUT; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS; THYMUS GLAND;

MUS;

EID: 84876175038     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061200     Document Type: Article

References (59)

1. Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, et al. (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61: 283-357.
2. Abad C, Gomariz RP, Waschek JA, (2006) Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP. Curr Top Med Chem 6: 151-163.
3. Tan YV, Waschek JA, (2011) Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis. ASN Neuro 3: 195-212.
4. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, et al. (2000) Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52: 269-324.
5. Delgado M, Pozo D, Ganea D, (2004) The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 56: 249-290.
6. Wainwright DA, Xin J, Sanders VM, Jones KJ, (2008) Differential actions of pituitary adenylyl cyclase-activating polypeptide and interferon gamma on Th2- and Th1-associated chemokine expression in cultured murine microglia. J Neurodegener Regen 1: 31-34.
7. Delgado M, Gonzalez-Rey E, Ganea D, (2004) VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells. FASEB J 18: 1453-1455.
8. Delgado M, Leceta J, Sun W, Gomariz RP, Ganea D, (2000) VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expression. Ann N Y Acad Sci 921: 68-78.
9. Delgado M, Leceta J, Ganea D, (2002) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cells. FASEB J 16: 1844-1846.
10. Kato H, Ito A, Kawanokuchi J, Jin S, Mizuno T, et al. (2004) Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells. Mult Scler 10: 651-659.
11. Armstrong BD, Hu Z, Abad C, Yamamoto M, Rodriguez WI, et al. (2004) Induction of neuropeptide gene expression and blockade of retrograde transport in facial motor neurons following local peripheral nerve inflammation in severe combined immunodeficiency and BALB/C mice. Neuroscience 129: 93-99.
12. Mei Q, Sundler F, (1998) Changes in pituitary adenylate cyclase activating peptide and vasoactive intestinal peptide innervation of rat oxyntic mucosa during ulcer healing. Neuropeptides 32: 527-535.
13. Jongsma Wallin H, Pettersson LM, Verge VM, Danielsen N, (2003) Effect of anti-nerve growth factor treatment on pituitary adenylate cyclase activating polypeptide expression in adult sensory neurons exposed to adjuvant induced inflammation. Neuroscience 120: 325-331.
14. Zhang Y, Danielsen N, Sundler F, Mulder H, (1998) Pituitary adenylate cyclase-activating peptide is upregulated in sensory neurons by inflammation. Neuroreport 9: 2833-2836.
15. Abad C, Martinez C, Leceta J, Juarranz MG, Delgado M, et al. (2002) Pituitary adenylate-cyclase-activating polypeptide expression in the immune system. Neuroimmunomodulation 10: 177-186.
16. Gaytan F, Martinez-Fuentes AJ, Garcia-Navarro F, Vaudry H, Aguilar E, (1994) Pituitary adenylate cyclase-activating peptide (PACAP) immunolocalization in lymphoid tissues of the rat. Cell Tissue Res 276: 223-227.
17. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH, (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162: 1-11.
18. Lourenco EV, La Cava A, (2010) Natural regulatory T cells in autoimmunity. Autoimmunity 44: 33-42.
19. Bilate AM, Lafaille JJ (2011) Induced CD4(+)Foxp3(+) Regulatory T Cells in Immune Tolerance. Annu Rev Immunol.
20. McGeachy MJ, Stephens LA, Anderton SM, (2005) Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 175: 3025-3032.
21. Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, et al. (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13: 423-431.
22. Chen X, Fang L, Song S, Guo TB, Liu A, et al. (2009) Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3+ regulatory T cells through IL-7 signaling pathway. J Immunol 183: 6135-6144.
23. O'Connor RA, Malpass KH, Anderton SM, (2007) The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells. J Immunol 179: 958-966.
24. Tan YV, Abad C, Lopez R, Dong H, Liu S, et al. (2009) Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 106: 2012-2017.
25. Zhou X, Rodriguez WI, Casillas RA, Ma V, Tam J, et al. (1999) Axotomy-induced changes in pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP receptor gene expression in the adult rat facial motor nucleus. J Neurosci Res 57: 953-961.
26. Vizzard MA, (2000) Up-regulation of pituitary adenylate cyclase-activating polypeptide in urinary bladder pathways after chronic cystitis. J Comp Neurol 420: 335-348.
27. Cheng G, Yu A, Malek TR, (2011) T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev 241: 63-76.
28. Schrempf W, Ziemssen T, (2007) Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun Rev 6: 469-475.
29. Lang TJ, (2004) Estrogen as an immunomodulator. Clin Immunol 113: 224-230.
30. Pettersson LM, Heine T, Verge VM, Sundler F, Danielsen N, (2004) PACAP mRNA is expressed in rat spinal cord neurons. J Comp Neurol 471: 85-96.
31. Beaudet MM, Braas KM, May V, (1998) Pituitary adenylate cyclase activating polypeptide (PACAP) expression in sympathetic preganglionic projection neurons to the superior cervical ganglion. J Neurobiol 36: 325-336.
32. Nance DM, Sanders VM, (2007) Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 21: 736-745.
33. Lelievre V, Ghiani CA, Seksenyan A, Gressens P, de Vellis J, et al. (2006) Growth factor-dependent actions of PACAP on oligodendrocyte progenitor proliferation. Regul Pept 137: 58-66.
34. Armstrong BD, Abad C, Chhith S, Cheung-Lau G, Hajji OE, et al. (2008) Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide. Neuroscience 151: 63-73.
35. Reglodi D, Kiss P, Lubics A, Tamas A, (2011) Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des 17: 962-972.
36. Kohm AP, Carpentier PA, Anger HA, Miller SD, (2002) Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169: 4712-4716.
37. Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, et al. (2004) IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 16: 249-256.
38. Delgado M, Gonzalez-Rey E, Ganea D, (2005) The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J Immunol 175: 7311-7324.
39. Fernandez-Martin A, Gonzalez-Rey E, Chorny A, Ganea D, Delgado M, (2006) Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis. Eur J Immunol 36: 318-326.
40. Zelenay S, Bergman ML, Paiva RS, Lino AC, Martins AC, et al. (2010) Cutting edge: Intrathymic differentiation of adaptive Foxp3+ regulatory T cells upon peripheral proinflammatory immunization. J Immunol 185: 3829-3833.
41. Ma A, Koka R, Burkett P, (2006) Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 24: 657-679.
42. Banham AH, (2006) Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol 27: 541-544.
43. Hoyer KK, Dooms H, Barron L, Abbas AK, (2008) Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 226: 19-28.
44. Beyersdorf N, Balbach K, Hunig T, Kerkau T, (2006) Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation. Immunology 119: 441-450.
45. Ring S, Thome M, Pretsch L, Enk AH, Mahnke K, (2007) Expanded murine regulatory T cells: analysis of phenotype and function in contact hypersensitivity reactions. J Immunol Methods 326: 10-21.
46. Mucida D, Cheroutre H, (2010) The many face-lifts of CD4 T helper cells. Adv Immunol 107: 139-152.
47. Jadidi-Niaragh F, Mirshafiey A, (2011) Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 74: 1-13.
48. Reyes JL, Espinoza-Jimenez AF, Gonzalez MI, Verdin L, Terrazas LI, (2010) Taenia crassiceps infection abrogates experimental autoimmune encephalomyelitis. Cell Immunol 267: 77-87.
49. Delgado M, Ganea D, (1999) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Ets activation. J Biol Chem 274: 31930-31940.
50. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D, (1999) VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells. J Neuroimmunol 96: 167-181.
51. Delgado M, Leceta J, Ganea D, (2003) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia. J Leukoc Biol 73: 155-164.
52. Delgado M, Ganea D, (2001) VIP and PACAP enhance the in vivo generation of memory TH2 cells by inhibiting peripheral deletion of antigen-specific effectors. Arch Physiol Biochem 109: 372-376.
53. McColl SR, Mahalingam S, Staykova M, Tylaska LA, Fisher KE, et al. (2004) Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands. Lab Invest 84: 1418-1429.
54. Brudvik KW, Tasken K, (2011) Modulation of T cell immune functions by the prostaglandin E(2)- cAMP pathway in chronic inflammatory states. Br J Pharmacol 166: 411-419.
55. Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M, (2008) Cyclic AMP: master regulator of innate immune cell function. Am J Respir Cell Mol Biol 39: 127-132.
56. Vendetti S, Riccomi A, Sacchi A, Gatta L, Pioli C, et al. (2002) Cyclic adenosine 5′-monophosphate and calcium induce CD152 (CTLA-4) up-regulation in resting CD4+ T lymphocytes. J Immunol 169: 6231-6235.
57. Vendetti S, Patrizio M, Riccomi A, De Magistris MT, (2006) Human CD4+ T lymphocytes with increased intracellular cAMP levels exert regulatory functions by releasing extracellular cAMP. J Leukoc Biol 80: 880-888.
58. Bodor J, Bopp T, Vaeth M, Klein M, Serfling E,et al. Cyclic AMP underpins suppression by regulatory T cells. Eur J Immunol 42: 1375-1384.
59. Shalev I, Schmelzle M, Robson SC, Levy G, (2011) Making sense of regulatory T cell suppressive function. Semin Immunol 23: 282-292.